Contrast Media & Molecular Imaging

Contrast Media & Molecular Imaging is a monthly peer-reviewed scientific journal published by John Wiley & Sons since 2006 and by Hindawi Publishing Corporation since 2017. It covers the areas of contrast agents and molecular imaging, covering all areas of imaging technologies with a special emphasis on magnetic resonance imaging and positron emission tomography, but also all other in vivo imaging technologies such as x-Ray, CT, ultrasound etc. The current editor-in-chief is Luc Zimmer, professor of pharmacology at the (University of Lyon).[1], [2]. On 1 January 2017, the journal became fully open access due to a publishing partnership between John Wiley & Sons and the Hindawi Publishing Group, where the journal "remain[s] a Wiley title but will be published and hosted by Hindawi". Molecular imaging articles concentrate on the potential role played by MRI and PET contrast agents at visualizing, at the molecular or cellular level, the physiology and physio-pathological processes from animal models to humans.

Contrast Media & Molecular Imaging
DisciplineChemistry; Pharmacology; Medical imaging; Molecular imaging
LanguageEnglish
Edited byLuc Zimmer, University of Lyon & Hospices Civils de Lyon
Publication details
History2006-present
Publisher
John Wiley & Sons & Hindawi Publishing Corporation
FrequencyMonthly
Standard abbreviations
ISO 4Contrast Media Mol Imaging
Indexing
ISSN1555-4309 (print)
1555-4317 (web)
LCCN2005212234
OCLC no.58749692
Links

Annual Issues
  1. Development and Application of Nanoparticles in Biomedical Imaging [3]
  2. In Vivo Imaging of Inflammation and Infection [4]

Abstracting and indexing

The journal is abstracted and indexed in SciFinder, Scopus, and Web of Science.[1] The 2014 impact factor is 2.923. It is ranked 27th out of 125 journals in the category "Radiology, Nuclear Medicine and Medical Imaging".[5]

gollark: Yes, but there's a lot of data gathered which I think isn't something they need for that.
gollark: For example, companies can buy data someone collects and use it for price discrimination.
gollark: I mean, in *my* case, I find random giant companies having access to stuff like my browsing history creepy, which is a good reason to me. Other people might not think this. But there are other reasons.
gollark: Sure? It's a bit loosely defined but I guess so.
gollark: Also, there aren't "objective reason"s to do anything. The most you can say objectively is that "X is good/problematic because it satisfies/goes against Y goal", or maybe "I consider Y goal/X thing important".

See also

References
  1. {{cite journal|url=https://www.hindawi.com/journals/cmmi/editors/
  2. https://www.researchgate.net/profile/Luc_Zimmer
  3. https://www.hindawi.com/journals/cmmi/nanoparticles.development.application/
  4. https://www.hindawi.com/journals/cmmi/in.vivo.imaging/
  5. Institute for Scientific Information, Journal Citation Reports, 2015
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.